Hair Loss Risks with GLP-1 Drugs
Men predisposed to androgenetic alopecia have shown a higher risk of hair loss when using GLP-1 medications, as suggested by a recent Mendelian randomization study. This research was published in the Journal of Investigative Dermatology.
Increase in GLP-1 Prescriptions
Data from Truveta has indicated a 19% increase in GLP-1 prescribing among eligible Medicare beneficiaries following the launch of the Medicare GLP-1 Bridge program.
Recall of Weight Loss Supplement
The FDA has announced a recall for a weight loss supplement called Lipofit Extreme Fat Burner 2.0 due to contamination with undeclared fluoxetine and 2,4-dinitrophenol, a toxic pesticide.
Estrogen Patch Supply Issues
In light of ongoing shortages, the FDA is actively collaborating with manufacturers to increase the availability of estrogen patches.
Safety Concerns about GLP-1 Formulations
The FDA expanded its safety concerns regarding unapproved GLP-1 formulations, particularly those involving multidose vials, as detailed by Becker’s Hospital Review.
Pediatric Weight Management
In the phase III STEP Young trial, over 40% of children aged 6 to 11 years were able to reverse their obesity status after 68 weeks of treatment with semaglutide (Wegovy), according to Novo Nordisk.
Testosterone Screening Guidance Change
The Defense Department temporarily rescinded new clinical guidance requiring screening for testosterone deficiency in troops shortly after its release, noted in CBS News.
Effects of Semaglutide on Aging
Research in female mice suggested that late-life administration of semaglutide is linked to slowed biological aging indicators and a potential extension of lifespan, published in Nature.
Insulin Affordability Advocacy
The Endocrine Society has expressed support for the introduction of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act in the House, aimed at addressing insulin affordability issues.
GLP-1 as Adjunctive Therapy
A review highlighted that GLP-1 receptor agonists might be optimally positioned as adjunctive therapy alongside continuous positive airway pressure and other treatments for obesity-related obstructive sleep apnea, as reported in JAMA Otolaryngology–Head & Neck Surgery.
Fitness Tracker Inaccuracies
Recent studies indicate that smartwatches may grossly overestimate the calories burned during exercise, especially among individuals with higher body fat percentages, according to PLOS One.
Healthcare Changes for Minors
The Department of Justice has secured an agreement with Mount Sinai in New York, which will result in the health system no longer providing gender-affirming care for minors.
Challenges for Transgender Individuals with Autism
An online survey from Australia revealed that transgender and gender-diverse adults with autism face significant challenges in adhering to gender-affirming hormone therapy, as discussed in the Journal of Clinical Endocrinology & Metabolism.
Disclaimer: This content is for informational purposes only and does not substitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Fuente: https://www.medpagetoday.com/endocrinology/generalendocrinology/122927
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
